<html lang='en'>

<head>
  <meta charset='UTF-8' />
  <meta name='viewport' content='width=device-width, initial-scale=1' />
  <title>
    3. Neoplasia – Notes de XYGN
  </title>
  
    
      <meta property='og:description' content />
      <meta property='og:site_name' content='XYGN' />
    
    
      <base href='/' />
      <link href='static/favicon.png' rel='icon' />
    
    <link href='https://cdn.jsdelivr.net/npm/prismjs@1.23.0/themes/prism-dark.css' rel='stylesheet' />
<script src='https://cdn.jsdelivr.net/combine/npm/prismjs@1.23.0/prism.min.js,npm/prismjs@1.23.0/plugins/autoloader/prism-autoloader.min.js'></script>
<style>
body {background-color: #000000; background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 304 304' width='304' height='304'%3E%3Cpath fill='%2305f621' fill-opacity='0.97' d='M44.1 224a5 5 0 1 1 0 2H0v-2h44.1zm160 48a5 5 0 1 1 0 2H82v-2h122.1zm57.8-46a5 5 0 1 1 0-2H304v2h-42.1zm0 16a5 5 0 1 1 0-2H304v2h-42.1zm6.2-114a5 5 0 1 1 0 2h-86.2a5 5 0 1 1 0-2h86.2zm-256-48a5 5 0 1 1 0 2H0v-2h12.1zm185.8 34a5 5 0 1 1 0-2h86.2a5 5 0 1 1 0 2h-86.2zM258 12.1a5 5 0 1 1-2 0V0h2v12.1zm-64 208a5 5 0 1 1-2 0v-54.2a5 5 0 1 1 2 0v54.2zm48-198.2V80h62v2h-64V21.9a5 5 0 1 1 2 0zm16 16V64h46v2h-48V37.9a5 5 0 1 1 2 0zm-128 96V208h16v12.1a5 5 0 1 1-2 0V210h-16v-76.1a5 5 0 1 1 2 0zm-5.9-21.9a5 5 0 1 1 0 2H114v48H85.9a5 5 0 1 1 0-2H112v-48h12.1zm-6.2 130a5 5 0 1 1 0-2H176v-74.1a5 5 0 1 1 2 0V242h-60.1zm-16-64a5 5 0 1 1 0-2H114v48h10.1a5 5 0 1 1 0 2H112v-48h-10.1zM66 284.1a5 5 0 1 1-2 0V274H50v30h-2v-32h18v12.1zM236.1 176a5 5 0 1 1 0 2H226v94h48v32h-2v-30h-48v-98h12.1zm25.8-30a5 5 0 1 1 0-2H274v44.1a5 5 0 1 1-2 0V146h-10.1zm-64 96a5 5 0 1 1 0-2H208v-80h16v-14h-42.1a5 5 0 1 1 0-2H226v18h-16v80h-12.1zm86.2-210a5 5 0 1 1 0 2H272V0h2v32h10.1zM98 101.9V146H53.9a5 5 0 1 1 0-2H96v-42.1a5 5 0 1 1 2 0zM53.9 34a5 5 0 1 1 0-2H80V0h2v34H53.9zm60.1 3.9V66H82v64H69.9a5 5 0 1 1 0-2H80V64h32V37.9a5 5 0 1 1 2 0zM101.9 82a5 5 0 1 1 0-2H128V37.9a5 5 0 1 1 2 0V82h-28.1zm16-64a5 5 0 1 1 0-2H146v44.1a5 5 0 1 1-2 0V18h-26.1zm102.2 270a5 5 0 1 1 0 2H98v14h-2v-16h124.1zM242 149.9V160h16v34h-16v62h48v48h-2v-46h-48v-66h16v-30h-16v-12.1a5 5 0 1 1 2 0zM53.9 18a5 5 0 1 1 0-2H64V2H48V0h18v18H53.9zm112 32a5 5 0 1 1 0-2H192V0h50v2h-48v48h-28.1zm-48-48a5 5 0 0 1-9.8-2h2.07a3 3 0 1 0 5.66 0H178v34h-18V21.9a5 5 0 1 1 2 0V32h14V2h-58.1zm0 96a5 5 0 1 1 0-2H137l32-32h39V21.9a5 5 0 1 1 2 0V66h-40.17l-32 32H117.9zm28.1 90.1a5 5 0 1 1-2 0v-76.51L175.59 80H224V21.9a5 5 0 1 1 2 0V82h-49.59L146 112.41v75.69zm16 32a5 5 0 1 1-2 0v-99.51L184.59 96H300.1a5 5 0 0 1 3.9-3.9v2.07a3 3 0 0 0 0 5.66v2.07a5 5 0 0 1-3.9-3.9H185.41L162 121.41v98.69zm-144-64a5 5 0 1 1-2 0v-3.51l48-48V48h32V0h2v50H66v55.41l-48 48v2.69zM50 53.9v43.51l-48 48V208h26.1a5 5 0 1 1 0 2H0v-65.41l48-48V53.9a5 5 0 1 1 2 0zm-16 16V89.41l-34 34v-2.82l32-32V69.9a5 5 0 1 1 2 0zM12.1 32a5 5 0 1 1 0 2H9.41L0 43.41V40.6L8.59 32h3.51zm265.8 18a5 5 0 1 1 0-2h18.69l7.41-7.41v2.82L297.41 50H277.9zm-16 160a5 5 0 1 1 0-2H288v-71.41l16-16v2.82l-14 14V210h-28.1zm-208 32a5 5 0 1 1 0-2H64v-22.59L40.59 194H21.9a5 5 0 1 1 0-2H41.41L66 216.59V242H53.9zm150.2 14a5 5 0 1 1 0 2H96v-56.6L56.6 162H37.9a5 5 0 1 1 0-2h19.5L98 200.6V256h106.1zm-150.2 2a5 5 0 1 1 0-2H80v-46.59L48.59 178H21.9a5 5 0 1 1 0-2H49.41L82 208.59V258H53.9zM34 39.8v1.61L9.41 66H0v-2h8.59L32 40.59V0h2v39.8zM2 300.1a5 5 0 0 1 3.9 3.9H3.83A3 3 0 0 0 0 302.17V256h18v48h-2v-46H2v42.1zM34 241v63h-2v-62H0v-2h34v1zM17 18H0v-2h16V0h2v18h-1zm273-2h14v2h-16V0h2v16zm-32 273v15h-2v-14h-14v14h-2v-16h18v1zM0 92.1A5.02 5.02 0 0 1 6 97a5 5 0 0 1-6 4.9v-2.07a3 3 0 1 0 0-5.66V92.1zM80 272h2v32h-2v-32zm37.9 32h-2.07a3 3 0 0 0-5.66 0h-2.07a5 5 0 0 1 9.8 0zM5.9 0A5.02 5.02 0 0 1 0 5.9V3.83A3 3 0 0 0 3.83 0H5.9zm294.2 0h2.07A3 3 0 0 0 304 3.83V5.9a5 5 0 0 1-3.9-5.9zm3.9 300.1v2.07a3 3 0 0 0-1.83 1.83h-2.07a5 5 0 0 1 3.9-3.9zM97 100a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm0-16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16 16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16 16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm0 16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm-48 32a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16 16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm32 48a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm-16 16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm32-16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm0-32a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16 32a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm32 16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm0-16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm-16-64a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16 0a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16 96a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm0 16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16 16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16-144a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm0 32a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16-32a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16-16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm-96 0a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm0 16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16-32a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm96 0a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm-16-64a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16-16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm-32 0a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm0-16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm-16 0a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm-16 0a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm-16 0a3 3 0 1 0 0-6 3 3 0 0 0 0 6zM49 36a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm-32 0a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm32 16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zM33 68a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16-48a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm0 240a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16 32a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm-16-64a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm0 16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm-16-32a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm80-176a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16 0a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm-16-16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm32 48a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16-16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm0-32a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm112 176a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm-16 16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm0 16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm0 16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zM17 180a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm0 16a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm0-32a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16 0a3 3 0 1 0 0-6 3 3 0 0 0 0 6zM17 84a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm32 64a3 3 0 1 0 0-6 3 3 0 0 0 0 6zm16-16a3 3 0 1 0 0-6 3 3 0 0 0 0 6z'%3E%3C/path%3E%3C/svg%3E");}
</style>

  
  <!-- CSSSTART -->
  <script type='text/javascript' src='https://cdn.jsdelivr.net/combine/npm/twind/twind.umd.min.js,npm/twind/observe/observe.umd.min.js'></script><script type='text/javascript'>// Be silent to avoid complaining about non-tailwind classes
// https://github.com/tw-in-js/twind/discussions/180#discussioncomment-678272
console.log("ema: Twind: setup & observe")
twind.setup({mode: 'silent'})
window.emaTwindObs = twindObserve.observe(document.documentElement);</script>
  <!-- CSSEND -->

  <!-- Heist error element -->
  <style type='text/css'>
    strong.error {
      color: lightcoral;
      font-size: 90%;
      font-family: monospace;
    }
  </style>
  <!-- What goes in this file will appear on near the end of <head>--><link rel='preload' href='_emanote-static/fonts/Nunito/Nunito-Regular.ttf' as='font' type='font/ttf' crossorigin />
<link rel='preload' href='_emanote-static/fonts/Nunito/Nunito-ExtraBold.ttf' as='font' type='font/ttf' crossorigin />

<style>
  @font-face {
    font-family: 'Nunito';
    src: url('_emanote-static/fonts/Nunito/Nunito-Regular.ttf') format("truetype");
    font-display: swap;
  }

  @font-face {
    font-family: 'Nunito-Bold';
    src: url('_emanote-static/fonts/Nunito/Nunito-ExtraBold.ttf') format("truetype");
    font-display: swap;
  }

  body {
    font-family: 'Nunito', sans-serif;
  }

  h1,
  h2,
  h3,
  h4,
  h5,
  h6,
  header {
    font-family: 'Nunito-Bold', sans-serif;
  }
</style>
</head>

<!-- DoNotFormat -->


<!-- DoNotFormat -->

<body class='overflow-y-scroll bg-black-400'>
  
    <div class='container mx-auto'>

      
  <nav id='breadcrumbs' class='w-full text-gray-700 md:hidden'>
    <div class='flex justify-left'>
      <div class='w-full px-2 py-2 bg-gray-50'>
        <ul class='flex flex-wrap text-lg'>
          
            <li class='inline-flex items-center'>
              <a class='px-1 font-bold' href=''>
                Notes de XYGN
              </a>
              <svg fill='currentColor' viewBox='0 0 20 20' class='w-auto h-5 text-gray-400'>
                <path fill-rule='evenodd' d='M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z' clip-rule='evenodd'></path>
              </svg>
            </li>
          
            <li class='inline-flex items-center'>
              <a class='px-1 font-bold' href='class'>
                class
              </a>
              <svg fill='currentColor' viewBox='0 0 20 20' class='w-auto h-5 text-gray-400'>
                <path fill-rule='evenodd' d='M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z' clip-rule='evenodd'></path>
              </svg>
            </li>
          
            <li class='inline-flex items-center'>
              <a class='px-1 font-bold' href='Core'>
                Core
              </a>
              <svg fill='currentColor' viewBox='0 0 20 20' class='w-auto h-5 text-gray-400'>
                <path fill-rule='evenodd' d='M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z' clip-rule='evenodd'></path>
              </svg>
            </li>
          
            <li class='inline-flex items-center'>
              <a class='px-1 font-bold' href='class/Core/Pathology'>
                Pathology
              </a>
              <svg fill='currentColor' viewBox='0 0 20 20' class='w-auto h-5 text-gray-400'>
                <path fill-rule='evenodd' d='M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z' clip-rule='evenodd'></path>
              </svg>
            </li>
          
            <li class='inline-flex items-center'>
              <a class='px-1 font-bold' href='class/Core/Pathology/General'>
                General
              </a>
              <svg fill='currentColor' viewBox='0 0 20 20' class='w-auto h-5 text-gray-400'>
                <path fill-rule='evenodd' d='M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z' clip-rule='evenodd'></path>
              </svg>
            </li>
          
        </ul>
      </div>
    </div>
  </nav>


      <div class='flex flex-nowrap bg-gray-50 md:mt-8 md:shadow-2xl md:mb-8'>
        <!-- Sidebar column -->
        <nav id='sidebar' class='flex-shrink hidden leading-relaxed md:block md:sticky md:top-0 md:h-full md:w-48 xl:w-64'>
          <div class='px-2 py-2 text-gray-800'>

            <div id='indexing-links' class='flex flex-row float-right p-2 space-x-2 text-gray-500'>
              <a href='-/tags' title='View tags'>
                <svg style='width: 1rem;' class='hover:text-red-700' fill='none' stroke='currentColor' viewBox='0 0 24 24' xmlns='http://www.w3.org/2000/svg'>
                  <path stroke-linecap='round' stroke-linejoin='round' stroke-width='2' d='M7 7h.01M7 3h5c.512 0 1.024.195 1.414.586l7 7a2 2 0 010 2.828l-7 7a2 2 0 01-2.828 0l-7-7A1.994 1.994 0 013 12V7a4 4 0 014-4z'>
                  </path>
                </svg>
              </a>
              <a href='-' title='Expand full tree'>
                <svg style='width: 1rem;' class='hover:text-red-700' fill='none' stroke='currentColor' viewBox='0 0 24 24' xmlns='http://www.w3.org/2000/svg'>
                  <path stroke-linecap='round' stroke-linejoin='round' stroke-width='2' d='M4 8V4m0 0h4M4 4l5 5m11-1V4m0 0h-4m4 0l-5 5M4 16v4m0 0h4m-4 0l5-5m11 5l-5-5m5 5v-4m0 4h-4'>
                  </path>
                </svg>
              </a>
            </div>

            <div id='site-logo' class='pl-2'>
              <div class='flex items-center my-2 space-x-2 justify-left'>
                <a href='' title='Go to Home'>
                  
                    
                      <!-- The style width attribute here is to prevent huge
                      icon from displaying at those rare occasions when Tailwind
                      hasn't kicked in immediately on page load 
                      -->
                      <img style='width: 1rem;' class='transition transform hover:scale-110 hover:opacity-80' src='static/favicon.png' />
                    
                  
                </a>
                <a class='font-bold truncate' title='Go to Home' href=''>
                  Home
                </a>
              </div>
            </div>

            
              <!-- Variable bindings for this tree-->
  
    
      
      
    



  
  

<!-- Rendering of this tree -->
<div class='pl-2'>
  <!-- Node's rootLabel-->
  <div class='flex items-center my-2 space-x-2 justify-left'>
    
    
      <svg xmlns='http://www.w3.org/2000/svg' class='w-4 h-4 flex-shrink-0 inline text-gray-700' viewBox='0 0 20 20' fill='currentColor'>
        <path fill-rule='evenodd' d='M2 6a2 2 0 012-2h4l2 2h4a2 2 0 012 2v1H8a3 3 0 00-3 3v1.5a1.5 1.5 0 01-3 0V6z' clip-rule='evenodd'></path>
        <path d='M6 12a2 2 0 012-2h8a2 2 0 012 2v2a2 2 0 01-2 2H2h2a2 2 0 002-2v-2z'></path>
      </svg>
      
  
    <a class='font-bold hover:underline truncate' title='class' href='class'>
      class
    </a>
    
      
  </div>

  <!-- Node's children forest, displayed only on active trees
    TODO: Use <details> to toggle visibility?
  -->
  
    
      <!-- Variable bindings for this tree-->
  
    
  



  
  

<!-- Rendering of this tree -->
<div class='pl-2'>
  <!-- Node's rootLabel-->
  <div class='flex items-center my-2 space-x-2 justify-left'>
    
    
      <svg xmlns='http://www.w3.org/2000/svg' class='w-4 h-4 flex-shrink-0 inline text-gray-500' viewBox='0 0 20 20' fill='currentColor'>
        <path d='M2 6a2 2 0 012-2h5l2 2h5a2 2 0 012 2v6a2 2 0 01-2 2H4a2 2 0 01-2-2V6z'></path>
      </svg>
    
  
    <a class='hover:underline truncate' title='Clinics' href='Clinics'>
      Clinics
    </a>
    
      
        <span class='text-gray-300' title='2 children inside'>
          2
        </span>
      
    
  </div>

  <!-- Node's children forest, displayed only on active trees
    TODO: Use <details> to toggle visibility?
  -->
  
</div>
    
      <!-- Variable bindings for this tree-->
  
    
      
      
    



  
  

<!-- Rendering of this tree -->
<div class='pl-2'>
  <!-- Node's rootLabel-->
  <div class='flex items-center my-2 space-x-2 justify-left'>
    
    
      <svg xmlns='http://www.w3.org/2000/svg' class='w-4 h-4 flex-shrink-0 inline text-gray-700' viewBox='0 0 20 20' fill='currentColor'>
        <path fill-rule='evenodd' d='M2 6a2 2 0 012-2h4l2 2h4a2 2 0 012 2v1H8a3 3 0 00-3 3v1.5a1.5 1.5 0 01-3 0V6z' clip-rule='evenodd'></path>
        <path d='M6 12a2 2 0 012-2h8a2 2 0 012 2v2a2 2 0 01-2 2H2h2a2 2 0 002-2v-2z'></path>
      </svg>
      
  
    <a class='font-bold hover:underline truncate' title='Core' href='Core'>
      Core
    </a>
    
      
  </div>

  <!-- Node's children forest, displayed only on active trees
    TODO: Use <details> to toggle visibility?
  -->
  
    
      <!-- Variable bindings for this tree-->
  
    
  



  
  

<!-- Rendering of this tree -->
<div class='pl-2'>
  <!-- Node's rootLabel-->
  <div class='flex items-center my-2 space-x-2 justify-left'>
    
    
      <svg xmlns='http://www.w3.org/2000/svg' class='w-4 h-4 flex-shrink-0 inline text-gray-500' viewBox='0 0 20 20' fill='currentColor'>
        <path d='M2 6a2 2 0 012-2h5l2 2h5a2 2 0 012 2v6a2 2 0 01-2 2H4a2 2 0 01-2-2V6z'></path>
      </svg>
    
  
    <a class='hover:underline truncate' title='Microbiology' href='class/Core/Microbiology'>
      Microbiology
    </a>
    
      
        <span class='text-gray-300' title='2 children inside'>
          2
        </span>
      
    
  </div>

  <!-- Node's children forest, displayed only on active trees
    TODO: Use <details> to toggle visibility?
  -->
  
</div>
    
      <!-- Variable bindings for this tree-->
  
    
      
      
    



  
  

<!-- Rendering of this tree -->
<div class='pl-2'>
  <!-- Node's rootLabel-->
  <div class='flex items-center my-2 space-x-2 justify-left'>
    
    
      <svg xmlns='http://www.w3.org/2000/svg' class='w-4 h-4 flex-shrink-0 inline text-gray-700' viewBox='0 0 20 20' fill='currentColor'>
        <path fill-rule='evenodd' d='M2 6a2 2 0 012-2h4l2 2h4a2 2 0 012 2v1H8a3 3 0 00-3 3v1.5a1.5 1.5 0 01-3 0V6z' clip-rule='evenodd'></path>
        <path d='M6 12a2 2 0 012-2h8a2 2 0 012 2v2a2 2 0 01-2 2H2h2a2 2 0 002-2v-2z'></path>
      </svg>
      
  
    <a class='font-bold hover:underline truncate' title='Pathology' href='class/Core/Pathology'>
      Pathology
    </a>
    
      
  </div>

  <!-- Node's children forest, displayed only on active trees
    TODO: Use <details> to toggle visibility?
  -->
  
    
      <!-- Variable bindings for this tree-->
  
    
      
      
    



  
  

<!-- Rendering of this tree -->
<div class='pl-2'>
  <!-- Node's rootLabel-->
  <div class='flex items-center my-2 space-x-2 justify-left'>
    
    
      <svg xmlns='http://www.w3.org/2000/svg' class='w-4 h-4 flex-shrink-0 inline text-gray-700' viewBox='0 0 20 20' fill='currentColor'>
        <path fill-rule='evenodd' d='M2 6a2 2 0 012-2h4l2 2h4a2 2 0 012 2v1H8a3 3 0 00-3 3v1.5a1.5 1.5 0 01-3 0V6z' clip-rule='evenodd'></path>
        <path d='M6 12a2 2 0 012-2h8a2 2 0 012 2v2a2 2 0 01-2 2H2h2a2 2 0 002-2v-2z'></path>
      </svg>
      
  
    <a class='font-bold hover:underline truncate' title='General' href='class/Core/Pathology/General'>
      General
    </a>
    
      
  </div>

  <!-- Node's children forest, displayed only on active trees
    TODO: Use <details> to toggle visibility?
  -->
  
    
      <!-- Variable bindings for this tree-->
  
    
  



  


<!-- Rendering of this tree -->
<div class='pl-2'>
  <!-- Node's rootLabel-->
  <div class='flex items-center my-2 space-x-2 justify-left'>
    
    
      <svg class='w-4 h-4 flex-shrink-0 inline' fill='none' stroke='currentColor' viewBox='0 0 24 24' xmlns='http://www.w3.org/2000/svg'>
        <path stroke-linecap='round' stroke-linejoin='round' stroke-width='2' d='M7 21h10a2 2 0 002-2V9.414a1 1 0 00-.293-.707l-5.414-5.414A1 1 0 0012.586 3H7a2 2 0 00-2 2v14a2 2 0 002 2z'>
        </path>
      </svg>
    
  
    <a class='hover:underline truncate' title='1. Cell Injury' href='class/Core/Pathology/General/1.%20Cell%20Injury'>
      1. Cell Injury
    </a>
    
      
        
    
  </div>

  <!-- Node's children forest, displayed only on active trees
    TODO: Use <details> to toggle visibility?
  -->
  
</div>
    
      <!-- Variable bindings for this tree-->
  
    
  



  


<!-- Rendering of this tree -->
<div class='pl-2'>
  <!-- Node's rootLabel-->
  <div class='flex items-center my-2 space-x-2 justify-left'>
    
    
      <svg class='w-4 h-4 flex-shrink-0 inline' fill='none' stroke='currentColor' viewBox='0 0 24 24' xmlns='http://www.w3.org/2000/svg'>
        <path stroke-linecap='round' stroke-linejoin='round' stroke-width='2' d='M7 21h10a2 2 0 002-2V9.414a1 1 0 00-.293-.707l-5.414-5.414A1 1 0 0012.586 3H7a2 2 0 00-2 2v14a2 2 0 002 2z'>
        </path>
      </svg>
    
  
    <a class='hover:underline truncate' title='2. Inflammation' href='class/Core/Pathology/General/2.%20Inflammation'>
      2. Inflammation
    </a>
    
      
        
    
  </div>

  <!-- Node's children forest, displayed only on active trees
    TODO: Use <details> to toggle visibility?
  -->
  
</div>
    
      <!-- Variable bindings for this tree-->
  
  


  


<!-- Rendering of this tree -->
<div class='pl-2'>
  <!-- Node's rootLabel-->
  <div class='flex items-center my-2 space-x-2 justify-left'>
    
    
      <svg class='w-4 h-4 flex-shrink-0 inline' fill='none' stroke='currentColor' viewBox='0 0 24 24' xmlns='http://www.w3.org/2000/svg'>
        <path stroke-linecap='round' stroke-linejoin='round' stroke-width='2' d='M9 12h6m-6 4h6m2 5H7a2 2 0 01-2-2V5a2 2 0 012-2h5.586a1 1 0 01.707.293l5.414 5.414a1 1 0 01.293.707V19a2 2 0 01-2 2z'>
        </path>
      </svg>
      
  
    <a class='font-bold text-red-600 hover:underline truncate' title='3. Neoplasia' href='class/Core/Pathology/General/3.%20Neoplasia'>
      3. Neoplasia
    </a>
    
      
  </div>

  <!-- Node's children forest, displayed only on active trees
    TODO: Use <details> to toggle visibility?
  -->
  
    
  
</div>
    
      <!-- Variable bindings for this tree-->
  
    
  



  


<!-- Rendering of this tree -->
<div class='pl-2'>
  <!-- Node's rootLabel-->
  <div class='flex items-center my-2 space-x-2 justify-left'>
    
    
      <svg class='w-4 h-4 flex-shrink-0 inline' fill='none' stroke='currentColor' viewBox='0 0 24 24' xmlns='http://www.w3.org/2000/svg'>
        <path stroke-linecap='round' stroke-linejoin='round' stroke-width='2' d='M7 21h10a2 2 0 002-2V9.414a1 1 0 00-.293-.707l-5.414-5.414A1 1 0 0012.586 3H7a2 2 0 00-2 2v14a2 2 0 002 2z'>
        </path>
      </svg>
    
  
    <a class='hover:underline truncate' title='4. Immunity' href='class/Core/Pathology/General/4.%20Immunity'>
      4. Immunity
    </a>
    
      
        
    
  </div>

  <!-- Node's children forest, displayed only on active trees
    TODO: Use <details> to toggle visibility?
  -->
  
</div>
    
  
</div>
    
      <!-- Variable bindings for this tree-->
  
    
  



  
  

<!-- Rendering of this tree -->
<div class='pl-2'>
  <!-- Node's rootLabel-->
  <div class='flex items-center my-2 space-x-2 justify-left'>
    
    
      <svg xmlns='http://www.w3.org/2000/svg' class='w-4 h-4 flex-shrink-0 inline text-gray-500' viewBox='0 0 20 20' fill='currentColor'>
        <path d='M2 6a2 2 0 012-2h5l2 2h5a2 2 0 012 2v6a2 2 0 01-2 2H4a2 2 0 01-2-2V6z'></path>
      </svg>
    
  
    <a class='hover:underline truncate' title='Systemic' href='class/Core/Pathology/Systemic'>
      Systemic
    </a>
    
      
        <span class='text-gray-300' title='1 children inside'>
          1
        </span>
      
    
  </div>

  <!-- Node's children forest, displayed only on active trees
    TODO: Use <details> to toggle visibility?
  -->
  
</div>
    
  
</div>
    
      <!-- Variable bindings for this tree-->
  
    
  



  
  

<!-- Rendering of this tree -->
<div class='pl-2'>
  <!-- Node's rootLabel-->
  <div class='flex items-center my-2 space-x-2 justify-left'>
    
    
      <svg xmlns='http://www.w3.org/2000/svg' class='w-4 h-4 flex-shrink-0 inline text-gray-500' viewBox='0 0 20 20' fill='currentColor'>
        <path d='M2 6a2 2 0 012-2h5l2 2h5a2 2 0 012 2v6a2 2 0 01-2 2H4a2 2 0 01-2-2V6z'></path>
      </svg>
    
  
    <a class='hover:underline truncate' title='Pharmacology' href='class/Core/Pharmacology'>
      Pharmacology
    </a>
    
      
        <span class='text-gray-300' title='5 children inside'>
          5
        </span>
      
    
  </div>

  <!-- Node's children forest, displayed only on active trees
    TODO: Use <details> to toggle visibility?
  -->
  
</div>
    
  
</div>
    
      <!-- Variable bindings for this tree-->
  
    
  



  
  

<!-- Rendering of this tree -->
<div class='pl-2'>
  <!-- Node's rootLabel-->
  <div class='flex items-center my-2 space-x-2 justify-left'>
    
    
      <svg xmlns='http://www.w3.org/2000/svg' class='w-4 h-4 flex-shrink-0 inline text-gray-500' viewBox='0 0 20 20' fill='currentColor'>
        <path d='M2 6a2 2 0 012-2h5l2 2h5a2 2 0 012 2v6a2 2 0 01-2 2H4a2 2 0 01-2-2V6z'></path>
      </svg>
    
  
    <a class='hover:underline truncate' title='recall' href='recall'>
      recall
    </a>
    
      
        <span class='text-gray-300' title='1 children inside'>
          1
        </span>
      
    
  </div>

  <!-- Node's children forest, displayed only on active trees
    TODO: Use <details> to toggle visibility?
  -->
  
</div>
    
  
</div>
            
              <!-- Variable bindings for this tree-->
  
    
  



  
  

<!-- Rendering of this tree -->
<div class='pl-2'>
  <!-- Node's rootLabel-->
  <div class='flex items-center my-2 space-x-2 justify-left'>
    
    
      <svg xmlns='http://www.w3.org/2000/svg' class='w-4 h-4 flex-shrink-0 inline text-gray-500' viewBox='0 0 20 20' fill='currentColor'>
        <path d='M2 6a2 2 0 012-2h5l2 2h5a2 2 0 012 2v6a2 2 0 01-2 2H4a2 2 0 01-2-2V6z'></path>
      </svg>
    
  
    <a class='hover:underline truncate' title='privnotes' href='priv'>
      privnotes
    </a>
    
      
        <span class='text-gray-300' title='2 children inside'>
          2
        </span>
      
    
  </div>

  <!-- Node's children forest, displayed only on active trees
    TODO: Use <details> to toggle visibility?
  -->
  
</div>
            
              <!-- Variable bindings for this tree-->
  
    
  



  
  

<!-- Rendering of this tree -->
<div class='pl-2'>
  <!-- Node's rootLabel-->
  <div class='flex items-center my-2 space-x-2 justify-left'>
    
    
      <svg xmlns='http://www.w3.org/2000/svg' class='w-4 h-4 flex-shrink-0 inline text-gray-500' viewBox='0 0 20 20' fill='currentColor'>
        <path d='M2 6a2 2 0 012-2h5l2 2h5a2 2 0 012 2v6a2 2 0 01-2 2H4a2 2 0 01-2-2V6z'></path>
      </svg>
    
  
    <a class='hover:underline truncate' title='static' href='static'>
      static
    </a>
    
      
        <span class='text-gray-300' title='1 children inside'>
          1
        </span>
      
    
  </div>

  <!-- Node's children forest, displayed only on active trees
    TODO: Use <details> to toggle visibility?
  -->
  
</div>
            

          </div>
        </nav>

        <!-- Main body column -->
        <div class='flex-1 w-full overflow-x-auto bg-white'>
          <main class='px-4 py-4'>
            <h1 class='flex items-end justify-center mb-4 p-3 bg-red-100 text-5xl font-extrabold text-black rounded'>
  <a class='z-40 tracking-tighter '>
    3. Neoplasia
  </a>
</h1>
            <article class='overflow-auto'>
  <!-- What goes in this file will appear on top of note body-->
  <h2 id='-neoplasia' class='inline-block mt-6 mb-4 text-4xl font-bold text-gray-700 border-b-2'>// Neoplasia</h2>
    <p class='mb-3'>
      03.07.21 | 08:13 tags:
    </p>
  <hr class='mb-3' />
    <p class='mb-3'>
      <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>Neo - New Plasia - Growth</span>
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-decimal list-inside'>
      
        <li>
          Even when there is no stimulus ( such as growth factor), the cell continues replicating - distinct from hyperplasia and repair
        </li>
      
        <li>
          Monoclonal Growth
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Clonality determines number of cells involved in replication of a clone
        </li>
      
        <li>
          Monoclonal: Cells are derived from a single progenitor cell
        </li>
      
        <li>
          Polyclonal: Multiple cells produce daughter cells
        </li>
      
        <li>
          Clonality was historically determined by G6PD enzyme isoforms, but androgen receptor isoforms can be used (Both are present on X-chromosome)
    <ul class='my-3 ml-6 space-y-1 list-decimal list-inside'>
      
        <li>
          G6PD have multiple isoforms - A, B, C, D etcetra
        </li>
      
        <li>
          In females, only one isoform is inherited from each parent - X-linked inheritance
        </li>
      
        <li>
          One isoform is randolmly inactivated by <strong>lyonization</strong> which inactivates one X chromosome at random
        </li>
      
        <li>
          Normal ratio of active isoforms in any cell of a tissue is 1:1
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          50% of cells have G6PD-A and 50% have G6PDB
        </li>
      
    </ul>
  
        </li>
      
        <li>
          When hyperplasia occurs in these cells, 1:1 ratio is maintained in hyperplasia, as the derivative of hyperplasic cells is polyclonal
        </li>
      
        <li>
          Only one isoform is present in <strong>neoplasia</strong>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          As growth is monoclonal, thus only one isoform is present
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
        <li>
          Clonality of B-lymphocytes is determined by immunoglobulin light chain phenotype
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Ig is comprised of heavy and light chains
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          B cells express light chain phenotypes that are: kappa or lambda
        </li>
      
        <li>
          Normal kappa to lambda ratio is 3:1
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          This ratio is maintained in hyperplasia, such as during infection, which again is polyclonal
        </li>
      
        <li>
          When neoplasic growth such as <strong>lymphoma</strong> occurs, ratio is pushed to &gt;6:1 or is inverted (Κ:γ - 1:3 or &gt; 1:6) - due to monoclonal growth
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  <table class='mb-3'><thead><tr class='border-b-2 border-t-2 border-gray-300'><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Benign</th><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Malignant</th></tr></thead><tbody><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Remain Localized</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Invade locally</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Do not metastasize</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Have the potential to metastasize</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Slow growth</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Rapid growth</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Capsule is present except in Hemangioma</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Capsule is absent</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Well differentiated</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Poorly differentiated</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Good prognosis</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Poor Prognosis</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>-OMA suffix</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Seminoma, Lymphona, Carcinoma (epithelial cells) Sarcoma (Connective tissues)</td></tr></tbody></table>
    <p class='mb-3'>
      <strong>Nomenclature</strong>
    </p>
  <table class='mb-3'><thead><tr class='border-b-2 border-t-2 border-gray-300'><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Lineage of differentiation</th><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Benign</th><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Malignant</th></tr></thead><tbody><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Epithelium</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Adenoma - produces glands</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Adenocarcinoma</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'></td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Papilloma - produces papillary finger like structures</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Papillary carcinoma</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Mesenchyme</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Lipoma</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Liposarcoma</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Lymphocyte</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Non-existent</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Lymphoma/Leukemia</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Melanocyte</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Nevus (mole)</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Melanoma</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Husain Sattar’s brain</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Never benign - always proactive</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Pathoma</td></tr></tbody></table>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          
    <p class='mb-3'>
      Choristoma
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Normal tissue at an abnormal site [Ectopic rest of normal tissue]
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Hamartoma
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Abnormal tissue at normal sites
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Most common site -&gt; <em><strong>Lungs</strong></em>
        </li>
      
    </ul>
  
        </li>
      
        <li>
          Considered as preneoplastic lesions
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Teratoma -&gt;
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Growth in Totipotent cells
        </li>
      
        <li>
          Arises from 1 germ cell layer
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Most common site: Gonads &gt; Mediatinum <span class='line-through italic' title='Wiki-link does not refer to any known file'><a href='MRS' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'>MRS</a></span>
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  <img class='mb-3' src='static/Pasted image 20210703133008.png' alt='[[Pasted image 20210703133008.png]]' /><h2 id='components-of-neoplasm' class='inline-block mt-6 mb-4 text-4xl font-bold text-gray-700 border-b-2'>Components of Neoplasm</h2>
    <ul class='my-3 ml-6 space-y-1 list-decimal list-inside'>
      
        <li>
          Parenchyma
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Refers to the proliferating neoplastic cells
        </li>
      
    </ul>
  
        </li>
      
        <li>
          Stroma
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Refers to the connective tissue material present in the neoplasm
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          
    <p class='mb-3'>
      When there is more stroma -&gt; Firm appearance -<strong>Desmoplasia</strong>
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Linitis plastica - adenocarcinoma of stomach wall - leather-bottle appearance
        </li>
      
        <li>
          Colon cancer
        </li>
      
        <li>
          Breast cancer
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      When Parenchyma -&gt; Medullary appearance
    </p>
  
        </li>
      
    </ul>
  <h2 id='features-of-neoplasia' class='inline-block mt-6 mb-4 text-4xl font-bold text-gray-700 border-b-2'>Features of Neoplasia</h2><h3 id='1-anaplasia' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>1. Anaplasia</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          
    <p class='mb-3'>
      There’s a total absence of differentiation
    </p>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Nucleo:Cytoplasmic ratio can show this - Normal N:C ratio - 1:4 - Anaplastic N:C ratio - 1:1 - Histology shows highly basophilic
    </p>
  <img class='mb-3' src='static/Pasted image 20210703183310.png' alt='[[Pasted image 20210703183310.png]]' />
        </li>
      
        <li>
          
    <p class='mb-3'>
      Anaplastic cells show high pleomorphism
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Different morphologies - high variability
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Anaplastic cells undergo abnormal mitosis
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          
    <p class='mb-3'>
      Normal cells form 2 mitotic spindles -&gt; 2 daughter cells are produced
    </p>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Anaplastic cells have more than 2 spindles
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          
    <p class='mb-3'>
      3 spindles: Tripolar spindles
    </p>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      4 spindles: Quadripolar spindles
    </p>
  <img class='mb-3' src='static/Pasted image 20210703183532.png' alt='[[Pasted image 20210703183532.png]]' />
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Abnormal giant cells
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Reed sternberg cells <a href='class/Core/Pathology/General/2. Inflammation#^422fa8' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'></a>
        </li>
      
    </ul>
  <img class='mb-3' src='static/Pasted image 20210703184107.png' alt='[[Pasted image 20210703184107.png]]' />
        </li>
      
        <li>
          
    <p class='mb-3'>
      Totally irreversible Condition
    </p>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
    <blockquote class='py-0.5 px-4 mb-3 italic border-l-4 bg-gray-50 text-gray-600 border-gray-400 quote'>
      
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          AN - Abnormal Nucleocytoplasmic ratio - very high
        </li>
      
        <li>
          A - Abnormal mitosis
        </li>
      
        <li>
          PL - Pleomorphism, loss of polarity
        </li>
      
        <li>
          ASIA - IRREVERSIBLE
        </li>
      
    </ul>
  
    </blockquote>
  
    <blockquote class='py-0.5 px-4 mb-3 italic border-l-4 bg-gray-50 text-gray-600 border-gray-400 quote'>
      <img class='mb-3' src='static/Pasted image 20210703184253.png' alt='[[Pasted image 20210703184253.png]]' />
    </blockquote>
  <h3 id='2-rapid-rate-of-growth' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>2. Rapid Rate of Growth</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Minimum mass of tumor cells to be detected clinically is -&gt; Billion (10^9) cells (1g of tumor cells) <a href='#^a2faae' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'></a>
        </li>
      
        <li>
          Maximum number of cells compaitable with life -&gt; Trillion (10^12) cells
        </li>
      
    </ul>
  
    <blockquote class='py-0.5 px-4 mb-3 italic border-l-4 bg-gray-50 text-gray-600 border-gray-400 quote'>
      
    <p class='mb-3'>
      <strong>Warburg effect</strong>
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Even in the presence of sufficient oxygen, cancer/tumor cells undergo Glycolysis
        </li>
      
        <li>
          Pyurvate -&gt; Intermediates -&gt; Growth Factors synthesis -&gt; Tumor cell proliferation
        </li>
      
        <li>
          This is basically Aerobic Glycolysis but no EMP
        </li>
      
        <li>
          Physiologically seen in embryonic tissues, lymphoid cells where M2 isoform of pyurvate kinase is present
        </li>
      
    </ul>
  
    </blockquote>
  <div class='py-0.5 mb-3 text-sm'><pre><code class='language-none'>18 FDG - radioactive glucose sub-type that is non-metabolized is given to the patient
- As tumor cells leadto angiogenesis and thus are more vascularized, this 18-FDG is concentrated in the tumor. Normal cells have diffuse distribution of 18-FDG
- PET scan is done to localize tumors</code></pre></div><h3 id='3-invasion' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>3. Invasion</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Tumor cells secrete VEGF and FGF
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          They are responsible for angiogenesis
        </li>
      
        <li>
          Thus they are playing facilitatory role in the growth and spread of tumors
        </li>
      
    </ul>
  
        </li>
      
        <li>
          Without angiogenesis, tumor cells can grow only upto <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>1-2 mm</span>
        </li>
      
    </ul>
  
    <p class='mb-3'>
      ^b55de7
    </p>
  <div class='px-3 py-1 rounded shadow bg-yellow-100 mx-2 transform -skew-y-1 scale-95 hover:scale-100 hover:border-yellow-400 hover:shadow-lg border-t-8 border-yellow-200 mb-8 mt-8'>
    <p class='mb-3'>
      Anti-angiogenetics such as Angiostatin, endostatin [NATURAL] and drugs like Bevacizumab inhibit angiogenesis
    </p>
  </div><table class='mb-3'><thead><tr class='border-b-2 border-t-2 border-gray-300'><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Carcinoma</th><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Carcinoma In Situ</th></tr></thead><tbody><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Basement Membrane is affected</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Basement membrane is not affected</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'></td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Carcinoma is found only in the place where it first formed in the body</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'></td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>It is also known as preinvasive/non-invasive tumor - <strong>Stage 0 Cancer</strong></td></tr></tbody></table><h3 id='4-metastasis' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>4. Metastasis</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          
    <p class='mb-3'>
      It is the most reliable feature of Malignancy
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Pheochromocytoma
        </li>
      
        <li>
          Follicular thyroid tumor
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Follicular adenoma - benign
        </li>
      
        <li>
          Follicular carcinoma - malignant -metasasis
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Eventual accumulation of mutations results in invasion and spread <strong>Characteristics</strong>
    </p>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Downregulation of E-cadherin
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Cadherin keep cells attached with one another
        </li>
      
        <li>
          For tumor cells to spread, downregulation of E-cadherin
        </li>
      
        <li>
          The cell is attached to basement membrane - collagen IV and laminin <a href='class/Core/Pathology/General/2. Inflammation#^9c610e' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'></a>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Cell that detaches from neighbouring cells attach to the basement membrane by laminin
        </li>
      
        <li>
          Then they proceed to secrete collagenase and breakdown the collagen IV
        </li>
      
        <li>
          In the extracellular matrix, cells attach to fibronectin 
    <!-- DoNotFormat -->
    <!-- We use JavaScript because anchor links won't work if there is a <base> tag;
         see https://stackoverflow.com/a/34765348 
    -->
    <sup class='px-0.5'><a class='text-red-600 hover:underline' href='javascript:;' onclick="document.location.hash='#fn1';">1</a></sup>
    <!-- DoNotFormat -->
   and spreads locally
        </li>
      
        <li>
          It may gain access to vascular (hematogenous spread) or lymphatic spaces
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Epithelial -&gt; Mesenchymal Transition:
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          For spread of tumor, properties are up regulated and mesenchymal property is down regulated
        </li>
      
    </ul>
  <img class='mb-3' src='static/Pasted image 20210707104535.png' alt='[[Pasted image 20210707104535.png]]' />
        </li>
      
    </ul>
  
    <blockquote class='py-0.5 px-4 mb-3 italic border-l-4 bg-gray-50 text-gray-600 border-gray-400 quote'>
      
    <p class='mb-3'>
      Malignancy maybe present without metastasis in:
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-decimal list-inside'>
      
        <li>
          Basal cell carcinoma - Skin
        </li>
      
        <li>
          Glioma - CNS tumor
        </li>
      
    </ul>
  
    </blockquote>
  
    <p class='mb-3'>
      <strong>Metastasis are spread through:</strong>
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-decimal list-inside'>
      
        <li>
          
    <p class='mb-3'>
      Lymphatic spread - Property of <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>Carcinomas</span>
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Tumor cells are generally spread first to ==Sentinel lymph-nodes ==
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          
    <p class='mb-3'>
      Sentinel lymph node (SLN) is defined as the first lymph node (or nodes) on a direct lymphatic drainage pathway from a primary tumor site, and as such, is hypothesized as the most likely location to harbor occult metastasis.
    </p>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      These sentinel lymph nodes are used for assessing prognosis [the likely course of a medical condition.]
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          If on biopsy, tumor cells are negative, it usually means that the cancer is localized -&gt; Good prognosis as spread is limited
        </li>
      
        <li>
          If biopsy is positive, then the prognosis is <strong>poor</strong> and the spread is more extensive
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      SLNs are prognostic and can tell the extent of surgery
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Useful for
        </li>
      
    </ul>
  
    <ul class='my-3 ml-6 space-y-1 list-decimal list-inside'>
      
        <li>
          Breast cancer
        </li>
      
        <li>
          Vulval cancer
        </li>
      
        <li>
          Melanoma
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      These spread through Hematogenous route
    </p>
  
        </li>
      
    </ul>
  
        </li>
      
        <li>
          Sarcomas with lymphatic spread
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          <strong>S</strong>: Synovial
        </li>
      
        <li>
          <strong>C</strong>: Cell Clear Sarcoma
        </li>
      
        <li>
          <strong>A</strong>: Angiosarcoma
        </li>
      
        <li>
          <strong>R</strong>: Rhabdomyosarcoma
        </li>
      
        <li>
          <strong>E</strong>: Epithelial Cell Sarcoma
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  <img class='mb-3' src='static/Pasted image 20210706174513.png' alt='[[Pasted image 20210706174513.png]]' />
        </li>
      
        <li>
          
    <p class='mb-3'>
      Hematogenous Spread
    </p>
  
        </li>
      
    </ul>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Tumor cells penetrate <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>venous</span> walls better than artery due to thickness of the wall being higher in the latter
        </li>
      
        <li>
          Sarcomas generally spread through hematogenous spread
        </li>
      
        <li>
          Any part that receives more blood have higher metastatic spread
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Lungs &gt;&gt; Liver &gt;&gt; Kidneys(?)
        </li>
      
    </ul>
  
        </li>
      
        <li>
          Lymphatic spread does not occur in the following carcinomas: RCHF - Red Chilli Hot Feppers
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          <strong>R:</strong> Renal Cell Carcinoma
        </li>
      
        <li>
          <strong>C</strong> Choriocarcioma (plancental tissue)
        </li>
      
        <li>
          <strong>H</strong> Hepatocellular Carcinoma
        </li>
      
        <li>
          <strong>F</strong> Follicular Carcinoma of Thyroid
        </li>
      
    </ul>
  
        </li>
      
        <li>
          <strong>SCARE</strong> sarcomas have lymphatic spread
        </li>
      
    </ul>
  
    <ul class='my-3 ml-6 space-y-1 list-decimal list-inside'>
      
        <li>
          
    <p class='mb-3'>
      Direct Seeding
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Body cavities are involved directly
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Pleural cavity: Lung Cancer, Mesothelioma
        </li>
      
        <li>
          Pericardial Cavity: Cardiac cancer, Lung cancer
        </li>
      
        <li>
          Peritoneal Cavity:
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          
    <p class='mb-3'>
      Most commonly affected in direct seeding
    </p>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Responsible for
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Omental Caking - thickened omentum
        </li>
      
    </ul>
  <img class='mb-3' src='static/Pasted image 20210706175130.png' alt='[[Pasted image 20210706175130.png]]' />
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Malignant Ascites - accumulation of fluid
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Tumor markers such as Ca125 can assess the prognosis
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Commonly seen in ovarian tumors, esp. at older age
    </p>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Cerebrospinal Fluid - very rare
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Drop metastasis - drop by drop CSF fa
        </li>
      
        <li>
          Seen in brain tumor: Medulloblastoma
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  <h2 id='screening' class='inline-block mt-6 mb-4 text-4xl font-bold text-gray-700 border-b-2'>Screening</h2>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Approximately <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>30 divisions</span> (1,073,741,824) occur before the earliest clinical symptoms arise ^a2faae
        </li>
      
        <li>
          Each division -&gt; Increased chances of Increased mutation
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Cancers such as pancreatic, ovarian, lung carcinoma - cancers that are detected late are due to large growth area
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          These do not produce symptoms until late in the disease and would have undergone beyond &gt;30 divisions thus are very mutated cells
        </li>
      
        <li>
          Thus these cancers have poor prognosis
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
        <li>
          Screening seeks to lead to Detection of Dysplasia; Or detect carcinoma before clinical symptoms are manifested
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          e.g: Pap Smear: detects cervical dysplasia
        </li>
      
        <li>
          Mammography - detects in situ breast cancer before invasion -&gt; or detect before clinically palpable
        </li>
      
        <li>
          Prostate specific antigen (PSA) and Digital Rectal Exam (DRE): detection before carcinoma spreads
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Prostate carcinoma grows in the periphery thus doesn’t supress the urethra like in BPH
        </li>
      
        <li>
          Thus it is silent
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
        <li>
          Hemoccult (blood in stool) test and colonoscopy: detect colonic <em>adenoma</em> before it becomes colonic carcinoma / before it spreads
        </li>
      
    </ul>
  <h1 id='carcinogenesis' class='pb-2 mb-2 text-5xl font-bold text-center'>Carcinogenesis</h1>
    <blockquote class='py-0.5 px-4 mb-3 italic border-l-4 bg-gray-50 text-gray-600 border-gray-400 quote'>
      
    <p class='mb-3'>
      <strong>Hallmarks of Cancer</strong>
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-decimal list-inside'>
      
        <li>
          Self sufficiency of Growth Factors
        </li>
      
        <li>
          Insensitivity to growth inhibitors
        </li>
      
        <li>
          Altered Metabolism
        </li>
      
        <li>
          Uncontrolled Replication
        </li>
      
        <li>
          Evasion of Metabolism
        </li>
      
        <li>
          Invasion and Metastasis
        </li>
      
        <li>
          Sustained Angiogenesis
        </li>
      
        <li>
          Evasion of host-immune response
        </li>
      
        <li>
          Tumor promoting inflammation
        </li>
      
        <li>
          Genomic instability
        </li>
      
        <li>
          Warburg effect
        </li>
      
    </ul>
  
    </blockquote>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Mutations result in cancer formation
        </li>
      
        <li>
          Carcinogens include chemicals, oncogenic viruses and radiation
        </li>
      
    </ul>
  <img class='mb-3' src='static/Pasted image 20210704095022.png' alt='[[Pasted image 20210704095022.png]]' />
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          <strong>Chemicals</strong>:
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Aflatoxins -&gt; Hepatocellular carcinoma: Common in Africa
        </li>
      
        <li>
          Alkylating agents -&gt; due to chemotherapy: <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>side efect</span> <a href='class/Core/Pharmacology/Chemotherapy/Antineoplastics' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'>Antineoplastics</a> ^f85b3c
        </li>
      
        <li>
          Alcohol -&gt; SCC of OP, Upper Esophagus, pancreatitis -&gt; pancreatic carcinoma, Cirrhosis -&gt; Hepatocellular carcinoma
        </li>
      
        <li>
          Arsenic -&gt; SCC of skin, lung cancer <strong>(smoking)</strong>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          <span xmlhtmlRaw><sup></span>Woman in england applied Arsenic onto the skin to prevent tan coz they secretly had orgy parties in the sun. Yes. (no they worked in fields lol. maybe they didn’t) <span xmlhtmlRaw></sup></span>
        </li>
      
    </ul>
  
        </li>
      
        <li>
          Asbestos -&gt; Lung carcinoma &gt;&gt; mesothelioma (pleural)
        </li>
      
        <li>
          Cigarette smoke <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>Most common carcinogen</span>-&gt; Lung cancer, OP, Esophagus, and <em><strong>Kidney and bladder</strong></em> (due to concentration of carcinogen while excretion)
        </li>
      
        <li>
          Nitrosamines -&gt; Intestinal Stomach Carcinoma -
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          <span xmlhtmlRaw><sub></span>Waifus in japan eat smoked meat ( ͡❛ ͜ʖ ͡❛) then get stomach cancer. sed. 
    <!-- DoNotFormat -->
    <!-- We use JavaScript because anchor links won't work if there is a <base> tag;
         see https://stackoverflow.com/a/34765348 
    -->
    <sup class='px-0.5'><a class='text-red-600 hover:underline' href='javascript:;' onclick="document.location.hash='#fn2';">2</a></sup>
    <!-- DoNotFormat -->
   <span xmlhtmlRaw></sub></span>
        </li>
      
    </ul>
  
        </li>
      
        <li>
          Napthylamine -&gt; derivative of cigarette <strong>smoke</strong>: Urothelial carcinoma of bladder
        </li>
      
        <li>
          Vinyl chloride -&gt; Angiosarcoma of liver ~&gt; Used in PVC pipe industry - occupational exposure
        </li>
      
        <li>
          Si, Be, Ni, Cr -&gt; Lung cancer, occupational again
        </li>
      
    </ul>
  
        </li>
      
        <li>
          <strong>Oncogenic</strong>:
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          EBV: <em>Nasopharyngeal carcinoma</em>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Chinese and African descent more susceptible (like how china debt trapped them lmao)
        </li>
      
        <li>
          Neck mass presentation
        </li>
      
    </ul>
  
        </li>
      
        <li>
          HHV-8: Kaposi carcinoma (endothelial cells)
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          E. Eu males @ skin
        </li>
      
        <li>
          AIDS patients as secondary infection
        </li>
      
        <li>
          Transplants due to immunosupression
        </li>
      
    </ul>
  
        </li>
      
        <li>
          H-BV and H-CV: -&gt; HPC
        </li>
      
        <li>
          HTLV-1: Adult T-Cell Leukemia/Lymphoma
        </li>
      
        <li>
          High-risk HPV (Subtypes)
        </li>
      
    </ul>
  
        </li>
      
        <li>
          <strong>Radiation</strong>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Ionizing: Papillary carcinoma of thyroid
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Nuclear reactor accidents and radiothyroid
        </li>
      
        <li>
          Occurs due to hydroxyl free radicals (ionizing)
        </li>
      
    </ul>
  
        </li>
      
        <li>
          Non-ionizing: Skin -&gt; Basal&gt;Squamous&gt;Melanoma
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          UVB sunlight radiations
        </li>
      
        <li>
          Xeroderma pigmenotosum
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
    <p class='mb-3'>
      Disrupted
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Proto-oncogenes
        </li>
      
        <li>
          Tumor supressor genes
        </li>
      
    </ul>
  <h3 id='protooncogenes' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Protooncogenes</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          These are genes essential for cell growth and differentiation
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Mutations in these genes lead to unregulated cellular growth
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          These mutations are <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>gain of function mutation</span>
        </li>
      
        <li>
          This leads tumor cells to become self-sufficient
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  <img class='mb-3' src='static/Pasted image 20210705173150.png' alt='[[Pasted image 20210705173150.png]]' />
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Categories of proto-oncogenes that produce:
    <ul class='my-3 ml-6 space-y-1 list-decimal list-inside'>
      
        <li>
          Growth Factors
        </li>
      
        <li>
          Growth factor receptors
        </li>
      
        <li>
          Signal Transducers
        </li>
      
        <li>
          Cell Cycle regulators
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  <img class='mb-3' src='static/Pasted image 20210705151649.png' alt='[[Pasted image 20210705151649.png]]' />
    <ul class='my-3 ml-6 space-y-1 list-decimal list-inside'>
      
        <li>
          
    <p class='mb-3'>
      <em><strong>Growth Factors</strong></em>
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          <strong>PDGF</strong> usually divides the astrocyte
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Mutation of SIS gene leads to astrocyte production of PDGFB (<span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>autocrine</span>)
        </li>
      
        <li>
          This autocrine overexpression leads to a loop of overgrowth -&gt; <strong>Astrocytoma</strong> a type of glioma
        </li>
      
    </ul>
  
        </li>
      
        <li>
          <strong>HGF</strong>: Hepatocyte Growth Factor
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Liver cancer
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      <em><strong>Growth Factor Receptors</strong></em>
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          When excess growth factor receptors are expressed, a simple stimulus by a single GF -&gt; overstimulation of growth signals
        </li>
      
        <li>
          These are associated with tyrosine kinase
        </li>
      
    </ul>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          <strong>ERBB2</strong> [HER2/neu] -&gt; amplified in <strong>subset</strong> of <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>breast cancer</span>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Trastuzumab is a MAB against HER2/neu
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          <strong>RET</strong> -&gt; <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>medullary carcinoma of thyroid</span>: associated with MEN2A MEN2B
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          MEN2A and 2B are types of Multiple Endocrine Neoplasia, a syndrome in which tumors are developed in endocrine organs
        </li>
      
        <li>
          2A and 2B cause medularry carcinoma of thyroid
        </li>
      
        <li>
          If <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>Pheocromocytoma</span> or mucosal neuromas (feature of MEN2B) is present, then <strong>RET</strong> mutation studies can be done and if positive, thyroid can be removed <span class='line-through italic' title='Wiki-link does not refer to any known file'><a href='Endocrine' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'>Endocrine</a></span>
        </li>
      
    </ul>
  
        </li>
      
        <li>
          <strong>KIT</strong> -&gt; <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>GIT</span> stromal tumor
        </li>
      
        <li>
          <strong>ERB-B1</strong> - lung cancer
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      <em><strong>Signal Transducers</strong></em>
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          
    <p class='mb-3'>
      Normally 1 receptor molecule has only 1 signal transducer
    </p>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      If however multiple signal transducers are produced due to mutation, excess transduction occurs
    </p>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      <strong>RAS</strong> gene family
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          70-80% of cancers are due to this mutation
        </li>
      
        <li>
          GTP-binding protein function
        </li>
      
        <li>
          RAS usually sits in off state - GDP with growth factor receptors
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          When activated, GTP is bound, and RAS-GTP complex acts as a messenger
        </li>
      
    </ul>
  
        </li>
      
        <li>
          RAS has the ability to dephosphorylate
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Augmented by GTPase Associated Protein - Neurofibromin (an example of tumor suppressor gene)
        </li>
      
    </ul>
  
        </li>
      
        <li>
          RAS mutations lead to loss of this ability leading to prolonged activated RAS
        </li>
      
        <li>
          This causes excess transduction
        </li>
      
    </ul>
  
    <blockquote class='py-0.5 px-4 mb-3 italic border-l-4 bg-gray-50 text-gray-600 border-gray-400 quote'>
      
    <p class='mb-3'>
      K-RAS - Colon Cancer***** H-RAS - Kidney and bladder cancer N-RAS - Melanoma
    </p>
  
    </blockquote>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      <strong>ABL</strong>
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          
    <p class='mb-3'>
      Non-receptor Tyrosine kinase (i.e, they are cytosolic rather than receptor bound)
    </p>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>9:22</span> translocation
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          ABL:BCR 9:22 switch up
        </li>
      
        <li>
          This leads to ABL-BCR fusion gene
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Leads to overactivity of tyrosine kinase which causes cancer
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Causes <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>CML
    <!-- DoNotFormat -->
    <!-- We use JavaScript because anchor links won't work if there is a <base> tag;
         see https://stackoverflow.com/a/34765348 
    -->
    <sup class='px-0.5'><a class='text-red-600 hover:underline' href='javascript:;' onclick="document.location.hash='#fn3';">3</a></sup>
    <!-- DoNotFormat -->
   and some ALL
    <!-- DoNotFormat -->
    <!-- We use JavaScript because anchor links won't work if there is a <base> tag;
         see https://stackoverflow.com/a/34765348 
    -->
    <sup class='px-0.5'><a class='text-red-600 hover:underline' href='javascript:;' onclick="document.location.hash='#fn3';">3</a></sup>
    <!-- DoNotFormat -->
   types</span>
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          ALL is usually associated with children
        </li>
      
        <li>
          ALL with 9:22 translocation has poor prognosis
        </li>
      
        <li>
          However CML with 9:22 translocation has good prognosis
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Tyrosine-Kinase addiction by tumors is called oncogene addiction (dependency)
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          This can be treated by Imatinib <a href='class/Core/Pharmacology/Chemotherapy/Antineoplastics' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'>Antineoplastics</a>
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      <strong>BRAF</strong>
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Responsible for MAP kinase
        </li>
      
    </ul>
  
    <blockquote class='py-0.5 px-4 mb-3 italic border-l-4 bg-gray-50 text-gray-600 border-gray-400 quote'>
      
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          <strong>Hairy cell leukemia - Associated 100%</strong>
        </li>
      
        <li>
          Benign Nevi (mole) - Associated 80%
        </li>
      
        <li>
          Melanoma - Associated 60%
        </li>
      
    </ul>
  
    </blockquote>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      <strong>Beta-catenin</strong> ^8c95e7
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Responsible for increased MYC (nuclear transcription facor) activity
        </li>
      
        <li>
          APC gene and E-Cadherin inhibit the activity
        </li>
      
        <li>
          Colon cancer - high risk <a href='#^79b23f' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'></a>
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      <em><strong>Nuclear Regulators</strong></em>
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          These are transcription factors that lead to upregulation of growth promoting proteins
        </li>
      
        <li>
          Also called as master regulator of the cell
        </li>
      
        <li>
          These increase
    <ul class='my-3 ml-6 space-y-1 list-decimal list-inside'>
      
        <li>
          Cyclin activity
        </li>
      
        <li>
          Telomerase activity
        </li>
      
        <li>
          Reprogram -&gt; Stemness (de-differentiation)
        </li>
      
    </ul>
  
        </li>
      
        <li>
          Mutations in these lead to excess growth promoting proteins
        </li>
      
        <li>
          <strong>c</strong>-MYC ^79b23f
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>Burkitt Lymphoma</span>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          translocation 8:14 -&gt;
        </li>
      
        <li>
          Immunoglobin H (IgH) is ON state in Chromosome 14
        </li>
      
        <li>
          <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>Chromosome 8 contains the MYC gene</span>
        </li>
      
        <li>
          This translocation leads to excess producion of c-MYC leading to high growth of cells <strong>(fastest rate of replication - highest mitotic activity)</strong>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          The starry sky appearance is due to:
    <ul class='my-3 ml-6 space-y-1 list-decimal list-inside'>
      
        <li>
          Tumor cells are sky - blue
        </li>
      
        <li>
          White areas : eating cells that are dying
        </li>
      
    </ul>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Macrophages consume dying cells leadng to starry sky
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
        <li>
          <strong>N</strong>-MYC
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>Neuroblastoma</span>
        </li>
      
    </ul>
  
        </li>
      
        <li>
          <strong>L</strong>-MYC
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>Lung carcinoma <em><strong>(Small Cell)</strong></em></span>
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      <em><strong>Cell Cycle Regulators</strong></em>
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Cell Cycle consists of G1-&gt;S [Most regulated step] -&gt; G2 -&gt; M
        </li>
      
        <li>
          G1 -&gt; S
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          In this it is made sure that S phase doesn’t contain mutations
        </li>
      
    </ul>
  
        </li>
      
        <li>
          Cyclins activate Cyclin-dependent kinase which phosphorylate
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Cyclins have OFF/ON state
        </li>
      
    </ul>
  
        </li>
      
        <li>
          <strong>CCND1</strong> [Cyclin D1]
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          
    <p class='mb-3'>
      <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>11:14</span> translocation
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Cyclin D sits on Chromosome 11 and it gets translocated to Chromosome 14 (IgH - <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>ON</span>)
        </li>
      
        <li>
          Leads to overexpression
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Mantle cell Lymphoma
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          In a lymph node, the B area (cortex of lymph node), outside the region of the follicle there’s a <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>Mantle</span> and outside that there’s a Marginal zone
        </li>
      
    </ul>
  <img class='mb-3' src='static/Pasted image 20210705160906.png' alt='[[Pasted image 20210705160906.png]]' />
        </li>
      
        <li>
          
    <p class='mb-3'>
      Cyclin D1 is important for regulation of <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>G1 -&gt; S</span> phase
    </p>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
    <p class='mb-3'>
      : &gt; DEA Bitch!
    </p>
  <table class='mb-3'><thead><tr class='border-b-2 border-t-2 border-gray-300'><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Cyclin</th><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>CDK</th><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Cycle</th></tr></thead><tbody><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>D</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>4, 6</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>G0 phase to G1 checkpoint 1 (G1 -&gt; S)</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>E</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>2</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>G1 phase (G1 -&gt; S)</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>A</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>2, 1</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>S -&gt; G2</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>B</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>1</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Before (Checkpoint 2) and after M phase</td></tr></tbody></table>
    <blockquote class='py-0.5 px-4 mb-3 italic border-l-4 bg-gray-50 text-gray-600 border-gray-400 quote'>
      <img class='mb-3' src='static/Pasted image 20210705182159.png' alt='[[Pasted image 20210705182159.png]]' />
    </blockquote>
  
    <p class='mb-3'>
      : Mutations affecting other CDKs and cyclin E also occur in cancers, but they are infrequent, presumably because these factors are less important in control of the G1 -&gt; S transition, which has a preeminent role in regulating tumor growth rates.
    </p>
  <img class='mb-3' src='static/Pasted image 20210705182739.png' alt='[[Pasted image 20210705182739.png]]' /><table class='mb-3'><thead><tr class='border-b-2 border-t-2 border-gray-300'><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>CDK Inhibitor</th><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>CDK Inhbited</th></tr></thead><tbody><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>p21 - p27 family</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>All CDKS</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>p16,17, 18, 19</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>CDK4,CDK 6 (<strong>Cyclin D</strong>)</td></tr></tbody></table><h3 id='tumor-supressor-genes' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Tumor Supressor Genes</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          These are genes that decrease/suppress (as the name says dimwit) the risk of tumor formation : e.g: <strong>p53</strong> and <em><strong>Retinoblastoma (Rb)</strong></em>
        </li>
      
        <li>
          Mutations here are <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>loss of function mutation</span>
        </li>
      
    </ul>
  <table class='mb-3'><thead><tr class='border-b-2 border-t-2 border-gray-300'><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Cycle</th><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Gene</th></tr></thead><tbody><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>G1 -&gt; S</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Rb, p53</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>S -&gt; G2</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>p53</td></tr></tbody></table><img class='mb-3' src='static/Pasted image 20210707092822.png' alt='[[Pasted image 20210707092822.png]]' /><h4 id='p53' class='mt-6 mb-2 text-2xl font-bold text-gray-700'>p53</h4>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Most common genetic mutation seen in human cancers
        </li>
      
        <li>
          G1 -&gt; S phase traffic cop bitch
        </li>
      
        <li>
          p53 “verifies” DNA integrity before it enter S phase
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          
    <p class='mb-3'>
      In response to DNA damage, p53 slows the cell cycle and upregulates DNA repair enzymes
    </p>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      If DNA repair is not possible, <em>(such as too many high fucks inside the car wayyy too much cocaine broo)</em> due to excess mutations, then p53 nukes the entire cell via apoptosis
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-decimal list-inside'>
      
        <li>
          
    <p class='mb-3'>
      Calls in BAX which disrupts BCL2 -&gt; Cyt C <em>(cocaine stash caught rip)</em> leaks from the cell -&gt; apoptosis
    </p>
  
    <blockquote class='py-0.5 px-4 mb-3 italic border-l-4 bg-gray-50 text-gray-600 border-gray-400 quote'>
      <div xmlhtmlRaw><iframe src="https://open.spotify.com/embed/track/2udGjDmpK1dH9VGyw7nrei?theme=0" width="300" height="380" frameborder="0" allowtransparency="true" allow="encrypted-media"></iframe>
</div>
    </blockquote>
  
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      <strong>Both</strong> copies of p53 <em><strong>must</strong></em> be knocked out - <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>Knudson two-hit hypothesis</span> <em>cops take cocaine rip corrupt crack addicts</em>
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Loss is seen in &gt;50% of cancers
        </li>
      
        <li>
          Germline mutation results in knock out of one copy of p53 (1 corrupt fucker) - in <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>Li-Fraumeni syndrome</span> and the second hit is <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>somatic</span>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          <strong>S</strong> - Sarcoma
        </li>
      
        <li>
          <strong>L</strong> - Lymphoma
        </li>
      
        <li>
          <strong>O</strong> - Osteosarcoma
        </li>
      
        <li>
          <strong>C</strong> - CNS Tumor
        </li>
      
        <li>
          <strong>A</strong> - Adrenal Cortex Tumor
        </li>
      
        <li>
          <strong>B</strong> - Breast Cancer
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  <h4 id='retinoblastoma-rb' class='mt-6 mb-2 text-2xl font-bold text-gray-700'>Retinoblastoma (Rb)</h4><div class='px-3 py-1 rounded shadow bg-yellow-100 mx-2 transform -skew-y-1 scale-95 hover:scale-100 hover:border-yellow-400 hover:shadow-lg border-t-8 border-yellow-200 mb-8 mt-8'>
    <p class='mb-3'>
      Retinoblastoma is a cancer that starts in the retina
    </p>
  <img class='mb-3' src='static/Pasted image 20210705164527.png' alt='[[Pasted image 20210705164527.png]]' />
    <p class='mb-3'>
      Retinoblastoma (Rb, RB, RB1) protein is a tumor suppressor protein. It is the most common tumor supressor gene associated with cancers
    </p>
  </div>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          G1 -&gt; S
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          E2F - a transcription factor is required for this transition
        </li>
      
        <li>
          However Retinoblastoma is that old-ass overprotective parent who needs some phosphorylation (dowry) for release of E2F
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Guess the dowry? Oh yeah Cyclin D activated CDK4 Complex
        </li>
      
    </ul>
  
        </li>
      
        <li>
          The release of E2F lets the G1 to phase into S phase <em>(change of surname biatch)</em>
        </li>
      
    </ul>
  
        </li>
      
        <li>
          However if there’s a mutation in Rb, the E2F is constituively free <em>(rebellious daughter lmao no respect for parents these zoomers)</em>
        </li>
      
        <li>
          This results in tumor formation and uncontrolled cell growth
        </li>
      
        <li>
          Both copies of Rb must be knocked out - Knudson’s Two-Hit hypothesis
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          <em>Well, both parents are greedy.. both need dowry… how can you split :(</em>
    <ul class='my-3 ml-6 space-y-1 list-decimal list-inside'>
      
        <li>
          Sporadic mutation - Hits are somatic -&gt; Unilateral retinoblastoma - During birth, no genes are mutated - Bilateral retinoblastoma sporadic mutation is very rare as in order for tumor to be develop, <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'><strong>Both</strong></span> copies of Rb gene should be mutated of which the probability is extremely slim
        </li>
      
        <li>
          Germline mutation - bilateral retinoblastoma and <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>osteosarcoma</span>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          1 gene of the allele is mutated (Autosomal dominant)
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          One more mutation in the normal gene leads to loss of this heterozygosity
        </li>
      
    </ul>
  
        </li>
      
        <li>
          In germline mutation, the chance is higher relatively as one gene is knocked out and mutation of the other normal gene
        </li>
      
        <li>
          Thus Germline mutation has bilateral retinublastoma 
    <!-- DoNotFormat -->
    <!-- We use JavaScript because anchor links won't work if there is a <base> tag;
         see https://stackoverflow.com/a/34765348 
    -->
    <sup class='px-0.5'><a class='text-red-600 hover:underline' href='javascript:;' onclick="document.location.hash='#fn4';">4</a></sup>
    <!-- DoNotFormat -->
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  <h4 id='brca' class='mt-6 mb-2 text-2xl font-bold text-gray-700'>BRCA</h4>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          BRCA:BReast CAncer gene
    <ul class='my-3 ml-6 space-y-1 list-decimal list-inside'>
      
        <li>
          BRCA-1: Breast/ovarian cancer
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          presence of BRCA1 mutation is an indication for prophylactic mastectomy and Oopherectomy: <em>important in familiak variant of breast cancer</em>
        </li>
      
    </ul>
  
        </li>
      
        <li>
          BRCA-2: Male breast/prostate cancer
        </li>
      
    </ul>
  
        </li>
      
        <li>
          Normal role: involved in DNA repair
        </li>
      
    </ul>
  <h4 id='apc' class='mt-6 mb-2 text-2xl font-bold text-gray-700'>APC</h4>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          The APC protein is a negative regulator that controls beta-catenin concentrations and interacts with E-cadherin <a href='#^8c95e7' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'></a>
        </li>
      
        <li>
          Mutations of APC leads to inactivation of APC thus allowing activating mutations in beta-catenin -&gt; increased MYC activity -&gt; cell proliferation
        </li>
      
    </ul>
  <h2 id='cellular-metabolic-alterations' class='inline-block mt-6 mb-4 text-4xl font-bold text-gray-700 border-b-2'>Cellular Metabolic Alterations</h2><h3 id='regulators-of-apoptosis' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Regulators of Apoptosis</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          
    <p class='mb-3'>
      <a href='class/recall/Core/Pathology/1.%20Cell%20Injury' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'>1. Cell Injury</a> <a href='1. Cell Injury#^565948' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'></a>
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          BCL2 stabilizes Mitochondrial Outer Membrane - making it impermeable to Cyt C
        </li>
      
        <li>
          Yoinking (disruption) of BCL2 leads to Cyt. C to leave and activate apoptosis
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      In follicular Lymphoma overexpression of BCL2 is overexpressed
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-decimal list-inside'>
      
        <li>
          This is due to t(14;18)
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Bcl2 is on chromosome 18
        </li>
      
        <li>
          IgH is on Chromosome 14
        </li>
      
        <li>
          BCL2 is now on the <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>ON</span> Chromosome 14 -&gt; overexpression thus the mitochondrial membrane is suuuuuuuper stabilized
        </li>
      
        <li>
          This is normally okay, coz no apoptosis is… nice
        </li>
      
        <li>
          But in the follicle, B-cells are undergoing somatic hypermutation to increase diversity in antibodies <a href='4. Immunity#Proteinaceous Antigens' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'></a>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Basically Uyghurs getting experimented upon and the shit ones are killed off - except with this mutation they… don’t die….
        </li>
      
        <li>
          i.e, naive B-cells that go to lymph node (the college) and then fail to produce antibody -&gt; apoptosis
        </li>
      
        <li>
          If no apoptosis occurs, then Follicular Lymphoma occurs
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      <strong>Altered Autophagy</strong> maybe present depending upon the need of cancer cells
    </p>
  
        </li>
      
    </ul>
  <h3 id='upregulation-and-downregulation' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Upregulation and Downregulation</h3><div class='px-3 py-1 rounded shadow bg-yellow-100 mx-2 transform -skew-y-1 scale-95 hover:scale-100 hover:border-yellow-400 hover:shadow-lg border-t-8 border-yellow-200 mb-8 mt-8'>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Telomerase is necessary is required for cell immortality
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Normally telomeres shorten with cell divisions eventually leading to cellular sensecence : <strong>Hay Flick limit - 60-70 times</strong>
        </li>
      
        <li>
          Often, cancers have upregulated telomerase, an enzyme that preserves telomeres, normally present in stem and germ cells
        </li>
      
    </ul>
  
        </li>
      
        <li>
          <a href='#^b55de7' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'></a>
        </li>
      
        <li>
          Tumor cells also avoid immune surveillance for survival
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          They do this by downregulating MHC-I of the cells thus CD8+ T Cells cannot detect them
        </li>
      
        <li>
          They grow antigen negative variant
        </li>
      
        <li>
          Secretion of TgF-Beta, IL-10 : <strong>reduced inflammatory response</strong> <a href='class/Core/Pathology/General/2. Inflammation#^4f1c75' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'></a>
        </li>
      
        <li>
          Secretion of PgE2, VEgF -&gt; <strong><span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>T-cell migration is reduced</span></strong>
        </li>
      
        <li>
          Immune checkpoint bypass through
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          PD-L1 : inhibits T-cell Activation
        </li>
      
        <li>
          CTLA-4 : removes B7 molecules on APCs (tumor itself here) preventing binding to CD28 <span class='line-through italic' title='Wikilink [[4. Immunity]] is ambiguous; referring to one of: class/Core/Pathology/General/4. Immunity.md, class/recall/Core/Pathology/4. Immunity.md'><a href='4. Immunity' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'>4. Immunity</a></span>
        </li>
      
    </ul>
  
        </li>
      
        <li>
          Immunodeficiency (primary or secondary) increases the risk for cancer
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  </div>
    <p class='mb-3'>
      ^c7c179
    </p>
  <h3 id='oncometabolism' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Oncometabolism</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          A few enzymes have been revealed to have shown a new mechanism of oncogenenesis
        </li>
      
        <li>
          One such example is the Isocitrate Dehydrogenase - IDH, part of the Kreb’s cycle
        </li>
      
    </ul>
  <img class='mb-3' src='static/Pasted image 20210707103728.png' alt='[[Pasted image 20210707103728.png]]' />
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          2-HG in turn acts as an inhibitor of several other enzymes that require a metabolite called α-ketoglutarate as a cofactor.
        </li>
      
        <li>
          Among the proteins that are inhibited by 2-HG are several members of the TET family, including TET2, which are normally responsible for methylation of DNA
        </li>
      
        <li>
          IDH mutation seen in <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>glioma, AML, cholongiocarcinoma</span>
        </li>
      
    </ul>
  <h2 id='clinical-features' class='inline-block mt-6 mb-4 text-4xl font-bold text-gray-700 border-b-2'>Clinical Features</h2><table class='mb-3'><thead><tr class='border-b-2 border-t-2 border-gray-300'><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Benign</th><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Malignant</th></tr></thead><tbody><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Slow growing</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Rapid growing</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Well circumscribed (restricted)</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Poorly Circumscribed</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Distinct and mobile</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Infiltrative and fixed to surrounding tissues</td></tr></tbody></table>
    <blockquote class='py-0.5 px-4 mb-3 italic border-l-4 bg-gray-50 text-gray-600 border-gray-400 quote'>
      
    <p class='mb-3'>
      Biopsy or excision is generally required before a tumor can be classified as benign or malignant with certainty
    </p>
  
    </blockquote>
  <h3 id='histological-features' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Histological Features</h3><table class='mb-3'><thead><tr class='border-b-2 border-t-2 border-gray-300'><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Benign</th><th class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Malignant</th></tr></thead><tbody><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Well differentiated</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'><em>Usually</em> poorly differentiated</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Organized</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Disorganized (loss of polarity)</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Uniform</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Nuclear pleomorphism and hyperchromasia 
    <!-- DoNotFormat -->
    <!-- We use JavaScript because anchor links won't work if there is a <base> tag;
         see https://stackoverflow.com/a/34765348 
    -->
    <sup class='px-0.5'><a class='text-red-600 hover:underline' href='javascript:;' onclick="document.location.hash='#fn5';">5</a></sup>
    <!-- DoNotFormat -->
  </td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Nucleo:Cytoplasmic ratio is low</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>High Nuclear:Cytoplasmic ratio</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>No invasion</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Invasion maybe seen through Basement membrane or local tissue</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Minimal mitotic activity</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>High mitotic activity with atypical mitosis (such as more than 2 spindles)</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>No metastatic potential</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Metastatic potential is present - hallmark</td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'><a href='static/Pasted%20image%2020210706180243.png' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkEmbed'>File:Pasted image 20210706180243.png</a></td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'><a href='static/Pasted%20image%2020210706180256.png' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkEmbed'>File:Pasted image 20210706180256.png</a></td></tr><tr class='border-b-2 border-t-2 border-gray-300'><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Follicular <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>adenoma</span> of thryoid</td><td class='py-2 px-2 align-top border-r-2 border-l-2 border-gray-300'>Anaplastic <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>carcinoma</span> of thyroid</td></tr></tbody></table><h3 id='immunohistochemistry' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Immunohistochemistry</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Immunohistochemistry is used to characterize tumors that are difficult to classify on histology
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          An antibody against a particular target is labelled with a brown stain (IHC stain) which then binds to the specific antigen that may help to subclassify the cell type
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  <img class='mb-3' src='static/Pasted image 20210706181750.png' alt='[[Pasted image 20210706181750.png]]' />
    <p class='mb-3'>
      The most well diff. carcinoid tumor &lt;-&gt; least differentiated small cell carcinoma - Differentiated by <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>Chromogranin</span>
    </p>
  <img class='mb-3' src='static/Pasted image 20210706181849.png' alt='[[Pasted image 20210706181849.png]]' /><h3 id='screening-1' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Screening</h3>
    <p class='mb-3'>
      <a href='#Screening' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'></a>
    </p>
  <h3 id='serum-tumor-markers' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Serum Tumor markers</h3>
    <p class='mb-3'>
      A. Proteins released by tumor into serum (e.g., PSA) B. Useful for <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>screening</span>, monitoring response to treatment, and monitoring recurrence C. Elevated levels still <em><strong>requires tissue biopsy</strong></em> for diagnosis of carcinoma (e.g., biopsy of prostate with elevated PSA).
    </p>
  <h3 id='grading' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Grading</h3>
    <p class='mb-3'>
      A. Microscopic assessment ofdifferentiation (i.e., howmuch a cancer resembles the tissue in which it grows); takes into account architectural and nuclear features 1. Well differentiated (low grade)-resembles normal parent tissue 2. Poorly differentiated (high grade)-does not resemble parent tissue B. Important for determining prognosis; well-differentiated cancers have better prognosis than poorly-differentiated cancers.
    </p>
  <h3 id='staging' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Staging</h3>
    <p class='mb-3'>
      A. Assessment ofsize and spread ofa cancer B. Key prognostic factor; more important than grade C. Determined after final surgical resection ofthe tumor D. Utilizes TNM staging system
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-decimal list-inside'>
      
        <li>
          T - tumor (size and/or depth of invasion) e.g: <code class='py-0.5 px-1 rounded bg-gray-700 text-sm text-white'>size in breast, depth in bowel</code>
        </li>
      
        <li>
          N - spread to regional lymph nodes; second most important prognostic factor
        </li>
      
        <li>
          M - metastasis; single <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>most important prognostic factor</span>
        </li>
      
    </ul>
  <h1 id='paraneoplastic-syndromes' class='pb-2 mb-2 text-5xl font-bold text-center'>Paraneoplastic Syndromes</h1>
    <p class='mb-3'>
      Syndrome non explicable par le caractéristiques du cancer:
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Direct spread
        </li>
      
        <li>
          Metastasis
        </li>
      
        <li>
          Indigenous hormones
        </li>
      
    </ul>
  
    <p class='mb-3'>
      Pourquoi c’est important?
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Can be an initial manifestation
        </li>
      
        <li>
          May mimic metastasis
        </li>
      
        <li>
          May indicate worsening condition
        </li>
      
    </ul>
  <h2 id='endocrinopathies' class='inline-block mt-6 mb-4 text-4xl font-bold text-gray-700 border-b-2'>Endocrinopathies</h2><h3 id='1-hypercalcemia' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>1. Hypercalcemia</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Most common paraneoplastic syndrome
        </li>
      
        <li>
          Presence is due to prostaglandins or parathyroid hormone related peptide
        </li>
      
        <li>
          Seen in:
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'><strong>Squamous cell carcinoma</strong></span> of lung
        </li>
      
        <li>
          Kidney cancer
        </li>
      
        <li>
          Breast cancer
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  <h3 id='2-cushing-syndrome' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>2. Cushing syndrome</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          A condition that occurs from exposure to high cortisol levels for a long time
        </li>
      
        <li>
          It is seen in carcinoid tumor
        </li>
      
        <li>
          Seen in <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'><strong>Small Cell</strong></span> lung cancer
        </li>
      
        <li>
          <em><strong>Most common endrocrinological PNS</strong></em>
        </li>
      
    </ul>
  <h3 id='3-siadh' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>3. SIADH</h3>
    <p class='mb-3'>
      Initialism of Syndrome of inappropriate antidiuretic hormone secretion
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Seen in lung cancer <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>[Small Cell Cancer]</span>
        </li>
      
        <li>
          CNS tumors
        </li>
      
        <li>
          Clinical manifestation: Hyponatriemia
        </li>
      
    </ul>
  <h3 id='4-hypoglycemia' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>4. Hypoglycemia</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Seen mostly in tumors with mesenchymal origin/connective tissue
        </li>
      
        <li>
          Seen in Fibrosarcoma (connective tissue)
        </li>
      
        <li>
          Hepatocellular carcinoma
        </li>
      
        <li>
          Ovarian cancer
        </li>
      
    </ul>
  <h3 id='5-polycthemia' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>5. Polycthemia</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Erythropoeitin
        </li>
      
        <li>
          HCC
        </li>
      
        <li>
          Kidney
        </li>
      
        <li>
          Fibromyoma (uterine muscles)
        </li>
      
        <li>
          Cerebellar hemangoblastoma
        </li>
      
    </ul>
  <h2 id='vascular-and-hematological' class='inline-block mt-6 mb-4 text-4xl font-bold text-gray-700 border-b-2'>Vascular and Hematological</h2><h3 id='1-venous-thrombophlebitis' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>1. Venous Thrombophlebitis</h3>
    <p class='mb-3'>
      <strong>Thrombophlebitis</strong> (throm-boe-fluh-BY-tis) is an inflammatory process that causes a blood clot to form and block one or more veins
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          
    <p class='mb-3'>
      Mucin is secreted by the tumor
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          This secretion slowly migrates causing migratory venous throbophlebitis
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          This is the <strong>Trousseau</strong> sign of malignancy/ <strong>Trousseau</strong> syndrome [Different from trossaeu sign seen in latent tetany] <a href='static/Pasted%20image%2020210707145427.png' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkEmbed'>File:Pasted image 20210707145427.png</a>
        </li>
      
        <li>
          a.k.a Thrombophlebitis Migrans
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Seen in AML-M3
    </p>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Pancreatic cancer
    </p>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Bronchogenic cancer/adenocarcinoma
    </p>
  
        </li>
      
    </ul>
  <h3 id='2-marantic-endocarditis' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>2. Marantic Endocarditis</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          A.k.a Non-bacterial Thrombotic Endocardiatis (NBTE)
        </li>
      
        <li>
          Due to secretion of mucin, <a href='#1 Venous Thrombophlebitis ' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'> similar to venous thrombophlebitis</a>
        </li>
      
        <li>
          Carcinoma of pancreas
        </li>
      
        <li>
          AML-M3
        </li>
      
    </ul>
  <h3 id='3-anemia' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>3. Anemia</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Seen in thyoma
        </li>
      
    </ul>
  <h2 id='dermatological' class='inline-block mt-6 mb-4 text-4xl font-bold text-gray-700 border-b-2'>Dermatological</h2><h3 id='acanthosis-nigricans' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Acanthosis nigricans</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          <strong>Thickened</strong> and **hyperpigmented ** skin Seen in:
        </li>
      
        <li>
          Stomach cancer
        </li>
      
        <li>
          Lung cancer
        </li>
      
        <li>
          Uterine malignancy
        </li>
      
    </ul>
  <h3 id='dermatomyositis' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Dermatomyositis</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          
    <p class='mb-3'>
      Involvement of skin and muscle tissue
    </p>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Involves Antip140Ab Antip155Ab
    </p>
  
        </li>
      
        <li>
          
    <p class='mb-3'>
      Seen in
    </p>
  
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Breast cancer
        </li>
      
        <li>
          Lung cancer
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  <h3 id='seberrheic-keratosis' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Seberrheic keratosis</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Sign of leser trelat
        </li>
      
    </ul>
  <img class='mb-3' src='static/Pasted image 20210707151409.png' alt='[[Pasted image 20210707151409.png]]' />
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Seen in <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>Stomach (most common)</span>
        </li>
      
    </ul>
  <h2 id='neurological' class='inline-block mt-6 mb-4 text-4xl font-bold text-gray-700 border-b-2'>Neurological</h2><h3 id='myasthenia-gravis' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Myasthenia Gravis</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Antibodies against: ACh receptor [Post-synaptic]
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Antibodies against calcium channel may also be [See Labort-Eaton]
        </li>
      
        <li>
          Both are responsible for decreased contractility
        </li>
      
    </ul>
  
        </li>
      
        <li>
          Seen in Thymoma
        </li>
      
    </ul>
  <h3 id='lambert-eaton-syndrome' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Lambert-Eaton Syndrome</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Anti-bodes against Pre-synaptic calcium channel of the nerves
        </li>
      
        <li>
          Causes late entry of calcium
        </li>
      
        <li>
          Seen in small cell carcinoma of lung
        </li>
      
    </ul>
  
    <p class='mb-3'>
      <span class='bg-yellow-200 px-2 py-0.5 rounded-xl'>L-E-S</span>
    </p>
  
    <blockquote class='py-0.5 px-4 mb-3 italic border-l-4 bg-gray-50 text-gray-600 border-gray-400 quote'>
      
    <p class='mb-3'>
      Late - Entry - SmallCell
    </p>
  
    </blockquote>
  <h3 id='opsoclonus' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Opsoclonus</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Random eye moments
        </li>
      
        <li>
          Seen in neuroblastoma and adrenal
        </li>
      
    </ul>
  <h3 id='limbic-encephalitis' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Limbic encephalitis</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          <strong>Limbic encephalitis</strong> represents a group of autoimmune conditions characterized by inflammation of the <strong>limbic</strong> system and other parts of the brain
        </li>
      
        <li>
          Anti-HU antibodies
        </li>
      
        <li>
          Strongly associated with small cell lung carcinoma
        </li>
      
    </ul>
  <h3 id='subacute-cerebellar-degeneration' class='mt-6 mb-2 text-3xl font-bold text-gray-700'>Subacute cerebellar degeneration</h3>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Anti-YO antibodies
        </li>
      
        <li>
          seen in
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Endometrial
        </li>
      
        <li>
          Ovarian cancer
        </li>
      
        <li>
          Breast cancer
        </li>
      
        <li>
          Thus wahmen are susceptible to this Paraneoplastic Syndrome
        </li>
      
    </ul>
  
        </li>
      
    </ul>
  <h2 id='osseus-soft-tissue' class='inline-block mt-6 mb-4 text-4xl font-bold text-gray-700 border-b-2'>Osseus Soft Tissue</h2>
    <ul class='my-3 ml-6 space-y-1 list-disc'>
      
        <li>
          Hypertrophic pulmonary osteoarthopathy
        </li>
      
        <li>
          causes clubbing of fingers
        </li>
      
    </ul>
  
    <div title='Footnotes' class='pt-2 mt-8 space-y-1 text-gray-500 transform scale-x-90 border-t-2'>
      <header class='font-semibold'>Footnotes</header>
      
        <div id='fn1'>
          <header class='italic'>
            1.
          </header>
          <div class='inline-block mb-2 ml-4'>
            high-molecular weight glycoprotein of the extracellular matrix that binds to membrane-spanning receptor proteins called integrins. <a href='https://en.wikipedia.org/wiki/Fibronectin' class='text-red-600 hover:underline' target='_blank' rel='noopener'>Fibronectin - Wikipedia</a>
          </div>
        </div>
      
        <div id='fn2'>
          <header class='italic'>
            2.
          </header>
          <div class='inline-block mb-2 ml-4'>
            It’s a joke sorry
          </div>
        </div>
      
        <div id='fn3'>
          <header class='italic'>
            3.
          </header>
          <div class='inline-block mb-2 ml-4'>
            CML: Chronic Myeloid Leukemia <span class='line-through italic' title='Wiki-link does not refer to any known file'><a href='Lymphoma' class='text-red-600 font-bold hover:underline' data-wikilink-type='WikiLinkNormal'>Lymphoma</a></span> | ALL: Acute Lymphoblastic Leukemia
          </div>
        </div>
      
        <div id='fn4'>
          <header class='italic'>
            4.
          </header>
          <div class='inline-block mb-2 ml-4'>
            <a href='https://en.wikipedia.org/wiki/Retinoblastoma#RB1' class='text-red-600 hover:underline' target='_blank' rel='noopener'>Retinoblastoma - Wikipedia</a>
          </div>
        </div>
      
        <div id='fn5'>
          <header class='italic'>
            5.
          </header>
          <div class='inline-block mb-2 ml-4'>
            Some nuclei are big and some are small. <strong>Hyperchromasia</strong> : The nucleus is really blue (hyperchromatic)
          </div>
        </div>
      
    </div>
  
</article>
            
            
  <section class='flex flex-wrap items-end justify-center my-4 space-x-2 space-y-2 font-mono text-sm'>
    
  </section>

          </main>
        </div>
      </div>
      <footer class='flex items-center justify-center mt-2 mb-8 space-x-4 text-center'>
  <div class='flex space-x-2 text-white'>
    <div>Powered by <a class='font-bold' href='https://note.ema.srid.ca/'>Emanote</a>
      
        
          <span class='font-mono text-sm tracking-tighter' title='And rendered with templates/layouts/book'>
            0.1.37.4
          </span>
        
      
    </div>
  </div>
</footer>

    </div>
  
</body>

</html>
